EGFRvIII peptide (PEPvIII)
Based on 1 publication(s) in Google Scholar
EGFRvIII peptide (PEPvIII) is a tumor-specific mutation that is widely expressed in glioblastoma multiforme (GBM) and other neoplasms and its expression enhances tumorigenicity. EGFRvIII peptide represents a truly tumor-specific target for antitumor immunotherapy.
For research use only. We do not sell to patients.
- CAS No.: 129112-17-0
- Formula: C70H111N19O24S
- Molecular Weight:1634.81
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
Publications Citing Use of MedChemExpress (MCE) EGFRvIII peptide (PEPvIII)
MoreAll EGFR Isoforms
More
Biological Activity
Description
Chemical Information
-
CAS No. 129112-17-0
-
Molecular Weight 1634.81
-
Formula C70H111N19O24S
-
Sequence
Leu-Glu-Glu-Lys-Lys-Gly-Asn-Tyr-Val-Val-Thr-Asp-His-Cys
-
Sequence Shortening
LEEKKGNYVVTDHC
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
EGFRvIII peptide (PEPvIII) Related Classifications
HY-P1828 Related Classifications
Powered by Bioz